Results 41 to 50 of about 1,156,270 (203)
New medication for Lennox-Gastaut syndrome management
Педиатрическая фармакология, 2022 Управление по санитарному надзору за качеством пищевых продуктов и медикаментов США (FDA) одобрило пероральный раствор фенфлурамина (Fintepla) — лекарственное средство для лечения судорог, связанных с синдромом Леннокса - Гасто (СЛГ) — редкой формой ...
article Editorial
doaj +1 more source
Corpus callosotomy in Lennox Gastaut syndrome
, 2022 Fauser S, Bien C, Rada A. Corpus callosotomy in Lennox Gastaut syndrome. Zeitschrift für Epileptologie . 2022.Corpus callosotomy is a palliative therapy option in patients with drop attacks or therapy-resistant bilateral tonic-clonic seizures (BTCS ...
Fauser, Susanne +2 more
core +1 more source
Anemia Associated with Lamotrigine
Pediatric Neurology Briefs, 1997 Two cases of anemia associated with lamotrigine adjunctive therapy for intractable epilepsy, one a 17-year-old with Lennox-Gastaut syndrome, are reported from Texas Tech University, Lubbock, TX.
J Gordon Millichap
doaj +1 more source
Benzodiazepines use in primary care England: Prescribing patterns and adverse consequences
British Journal of Clinical Pharmacology, EarlyView.Aims Benzodiazepines (BZDs) are commonly prescribed for anxiety and insomnia but carry risks such as dependence, adverse drug reactions (ADRs) and mortality. Despite deprescribing efforts, the influence of recent prescribing trends, COVID‐19 and adverse outcomes on prescribing patterns in England remains uncertain.
Alvina Chaudhry +3 more
wiley +1 more source
Efficacy and safety of rufinamide in pediatric epilepsy
Therapeutic Advances in Neurological Disorders, 2013 Rufinamide is a novel anticonvulsant medication approved by the US Food and Drug Administration (FDA) in 2008 for the treatment of seizures associated with Lennox–Gastaut syndrome in patients 4 years of age and older, based upon clinical trials ...
David T. Hsieh, Elizabeth A. Thiele
doaj +1 more source
Epilepsy in Christianson syndrome: Two cases of Lennox–Gastaut syndrome and a review of literature
Epilepsy & Behavior Reports, 2020 Christianson syndrome (CS) is an X-linked intellectual disorder caused by mutations in the SLC9A6 gene. Clinical features of CS include an inability to speak, truncal ataxia, postnatal microcephaly, hyperkinesis, and epilepsy. Almost all patients with CS
Azusa Ikeda +11 more
doaj +1 more source
Band Heterotopia and Lennox-Gastaut Syndrome: A Case Report
, 2018 Heterotopia, referred to as a limited or common neuronal migration disorder, may manifest clinically with mild mental retardation, epileptic seizures, psychiatric symptoms, or systemic disorders.
Mehmet Fatih GÖL, Füsun Ferda ERDOĞAN
core +1 more source
Prognosis of Infantile Spasms and L-G Syndrome
Pediatric Neurology Briefs, 1999 The occurrence, outcome, and prognostic factors of infantile spasms (IS) and Lennox-Gastaut syndrome (LGS) were determined in children treated in the Department of Pediatrics, University of Oulu, Finland, from Jan 1976 to Dec 1993.
J Gordon Millichap
doaj +1 more source
Epileptic Disorders, EarlyView.Abstract Objective To develop and evaluate a simple‐to‐use checklist to support physicians with the timely diagnosis of Lennox–Gastaut syndrome (LGS). Methods A panel of 10 pediatric and adult epileptologists used the International League Against Epilepsy (ILAE) criteria for LGS classification and definition to develop seven questions for the checklist,
Nicola Specchio +9 more
wiley +1 more source
Late-onset Lennox-Gastaut syndrome as a phenotype of 15q11.1q13.3 duplication [PDF]
, 2012 The clinical symptoms associated with chromosome 15q duplication syndrome manifest through a heterogeneous group of symptoms characterised by hypotonia, delay in motor skills and language development, cognitive and learning disabilities, autism spectrum ...
Guerra, C +11 more
core +3 more sources